ASC30
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity
Ascletis Pharma (China) Co · Phase 1/2 · Completed · Enrollment 115
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.